TILs as cell therapies
Dive deeper into the potential of TIL therapies in advancing cancer care.
TIL therapy starting material is delicate. But your TIL therapy workflow shouldn’t be. Our goal is to streamline, fortify, and simplify your workflow – every step of the way.
Our robust solutions grow with you with you, tackling tomorrow’s challenges and maintaining high efficiency and performance throughout.
Finding the right solution doesn’t have to be stressful. We’re here to help, let’s chat.
Webinar: Cell therapies up unTIL now
What opportunities lie ahead for TIL therapies? This webinar addresses this question and more.
Optimizing recovery on Sepax™ system
See this system’s flexible automation in action.
Stability study: Xuri™ IL-2 growth factor
An evaluation of cytokine concentrations in different media formulations over an 8-day period.
Poster collection: cell expansion
It rocks! Discover the benefits of rocking and the Xuri™ W25 system technology for cell expansion.
Application note: Xuri™ cell expansion systems
We investigated the optimal rocking rate and angle for the expansion of T cells so you don’t have to.
When it comes to kick-starting the TIL cell therapy manufacturing process, securely gathering source material plays a pivotal role.
But we know that developing such highly individualized therapies — for many —comes with challenges. That’s why we’ve gathered experiences and reflections from those in the field to help out.
Every moment matters.
Closed and automated TIL manufacturing solutions can simplify operations, reduce the risk of errors, and support scaling.
Plus, as you prepare the final product for patient delivery, automation can aid in getting the appropriate volumes, aliquots, and cell numbers with consistency and reproducibility.